Wyss Zurich: Liver Regeneration
A project of the Wyss Zurich
It is well known that the liver has the ability to regenerate. Liver resection (surgical removal of the diseased part of the liver) for the treatment of liver cancer has been carried out for a few decades, but many tumors are inoperable, notably because the removal of a too large piece of liver is fatal.
The Wyss Zurich project (Liver4Life) will develop a novel therapeutic strategy for liver regeneration consisting of: i) surgical resection of a small healthy piece of the liver from the patient; ii) growth of this piece outside of the body in a perfusion machine until a sufficient size is reached; iii) retransplantation of the regenerated liver to the original patient while removing the remaining diseased part.
Current perfusion systems are not able to keep a liver alive outside of the body for a sufficient time to allow growth and regeneration to occur. The challenging aim of the project is to extend the viability of liver tissue outside of the body for a few days and allow its growth. To this end, a perfusion machine will be developed, which will provide necessary nutrients and oxygen supply, and be equipped to monitor growth, as well as assess the functional capacity of the liver.
This technological advance will allow patients with formerly inoperable liver cancers to gain access to surgical resection. Additionally, performing autologous transplantation (patient receives liver tissue from his own body) will avoid the need for life-long immunosuppression and its associated severe side effects.
This novel regeneration strategy could also be used in allogenic liver transplantation (patient receives liver tissue from a donor) for end-stage chronic liver disease, where an organ transplant is the only treatment option. In this second approach, a healthy donor liver will be split into different parts that will be grown in the perfusion machine, yielding transplantable organs. With this approach, the organ donor pool would be increased, which would help to alleviate current donor organ shortage.
Keywords:
ex vivo liver perfusion, machine perfusion, liver preservation, ex vivo liver regeneration, perfusion medium, oxygenated liver perfusion